CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 51 enrolled
Drug / intervention
µCordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04512703
NCT04512703N/ACompleted
CompareCT.gov

Ambulatory Remote Patient Monitoring With the µCor Heart Failure and Arrhythmia Management System (PATCH) Feasibility Study

Zoll Medical Corporation·observational·Posted Aug 13, 2020·Updated Jun 3, 2021

In Brief

An observational study evaluating µCor for Heart Arrhythmia. Completed, enrolled 51 participants across 1 site.

Detailed Summary

Prospective, non-interventional, feasibility study. 8 months, from start of screening to finishing the study. Multi-center study, with a maximum of 8 centers in Europe. Health adult volunteers (21 years or older) and adult patients with a clinical indication for ambulatory outpatient cardiac monitoring. To observe the feasibility of remotely monitoring patients with the novel µCor Heart Failure and Arrhythmia Management System (µCor system ) that non-invasively captures thoracic fluid content, electrocardiogram, heart rate, respiratory rate, activity, and body posture. tory outpatient cardiac monitoring.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Arrhythmia
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 13, 2020
Enrollment StartOct 25, 2018
Primary CompletionAug 2, 2020
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 5.9 years ago

Interventions

µCordevice

Sensor Monitor for arrhythmia and other bio-metric markers